BioNTech's Q3 Adjusted Earnings, Revenue Fall; 2026 Revenue Outlook Raised

07:20 AM EST, 11/03/2026 (MT Newswires) -- BioNTech (BNTX) reported a Q3 adjusted earnings Tuesday of 1.76 euros ($1.97) per diluted share, down from 3.11 euros a year earlier. Four analysts polled by FactSet expected 0.49 euro. Revenue for the quarter ended Sept. 30 was 1.29 billion euros, compared with 1.52 billion euros a year earlier. Analysts expected 1.03 billion euros. The company raised its 2026 revenue outlook to between 1.70 billion euros and $1.90 billion euros, from 1.60 billion euros to 1.90 billion euros previously. Analysts expect 1.80 billion euros. BioNTech shares were up over 2% premarket activity. Price: 89.50, Change: +1.97, Percent Change: +2.25